GoodRx stockholders elect three Class I directors, ratify auditor, approve say-on-pay

GoodRx Holdings, Inc.

Elected Douglas Hirsch, Kelly J. Kennedy, and Agnes Rey-Giraud as Class I directors for terms through 2027.
Ratified appointment of PricewaterhouseCoopers LLP as independent auditor for fiscal 2024.
Advisory vote approved named executive officer compensation (2.82B votes for, 4.15M against).
Over 98.7% of combined voting power represented at the annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.